|
|
|
|
|
|
|
||
Original Article |
h-karas{at}rinshoken.or.jp
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
L chain germline transcription was found to be upregulated whereas the VH germline transcription was promptly downregulated. Notably, this alteration of the accessibility at the H and L chain loci was detected even before the induction of cellular differentiation became detectable by the change of surface phenotype. Thus, the pre-BCR signaling through Igβ appears to regulate the ordered Ig gene rearrangement by altering the Ig locus accessibility.
Key Words: pre–B cell receptor • surrogate light chain • allelic exclusion • B cell development • recombinase
The pre-BCR is composed of the membrane-bound form of the µH chain, Vpre-B/
To assess the proposed roles of the pre-BCR in regulation of Ig gene rearrangements, it is essential to show whether signaling through the pre-BCR actually suppresses or induces rearrangements at the H and L chain loci in vivo. However, to our knowledge no study has directly addressed this issue so far. The extremely low level of pre-BCR surface expression has hampered biochemical studies of pre-BCR signaling 1028, and a ligand triggering pre-BCR signaling remains unidentified. Moreover, transformed pre-B cell lines turned out not to be proper materials for analyzing the differentiation signals of the pre-BCR. To overcome these limitations, we have recently established a novel system that provides a superior way to analyze pre-BCR signaling by using bone marrow pro-B cells 29. The Ig
Antibodies.
Cell Preparation and Flow Cytometry.
PCR and Reverse Transcription PCR Analyses.
Ligation-mediated PCR Assays.
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
The diversity of antigen specificity among B cells is generated during their development through the rearrangement of gene segments encoding parts of the variable region of H and L chains 12. A common recombinase that recognizes a conserved recombination signal sequence (RSS) mediates all the rearrangement reactions 3. However, the rearrangement at a given locus is highly regulated during B cell development such that there is a clear-cut order of Ig gene rearrangements, namely, H chain gene rearrangements before L chain gene rearrangements 45. Once µH chain is expressed through a functional VHDHJH rearrangement in one allele of the H chain gene, the recombinase is directed towards the L chain locus, and the DHJH joint in the other allele of the H chain gene is not targeted for further VH to DHJH rearrangement. This regulation of recombinase targeting appears to be important for allelic exclusion, namely, the mechanism by which a single B cell has only one functionally rearranged H chain allele to ensure one immune specificity per cell 67. However, signals involved in this spatial and temporal regulation of the Ig gene rearrangements remained largely unknown. In this study, we examined the role of signaling through Igβ, a component of the pre-BCR, in this regulation by using a novel system to manipulate Ig gene rearrangements in vivo. 
5 surrogate L chain, and an Ig
/Igβ heterodimer 89. Its expression is restricted to the early pre-B cell stage of B cell development in which the rearrangement of the H chain gene but not yet the L chain gene has been completed 1011. The critical role of the pre-BCR in B cell generation was illuminated by creating pre-BCR–deficient mice in which B cell development was found to be severely impaired at the transition from the pro-B cell stage to the large pre-B cell stage 1213. The importance of the pre-BCR was further confirmed in humans by finding agammaglobulinemia patients with mutations of either the µH chain gene or the 5 gene 1415. The pre-BCR has been suggested to regulate several hallmark events associated with progression from the pro-B to pre-B cell stage, including Ig gene rearrangements 1617. Studies with transgenic mice indicated that allelic exclusion was mediated by the membrane-bound form of the µH chain 181920. Indeed, allelic exclusion was found to be violated in heterozygous mice carrying a targeted disruption of the membrane exon of the µH chain in one allele and an unmutated gene in the other allele 21. Furthermore, it has been shown that µH chain genes were not allelically excluded at the pre-B cell stage in 5-deficient mice 22. These results support the idea that the pre-BCR is involved in the process of allelic exclusion at the pre-B cell stage, even though an underlying mechanism including a signaling pathway remains to be elucidated. The membrane-bound form of the µH chain was also found to be functional in the induction of L chain rearrangements when expressed in in vitro pro-B cell lines 232425. On the other hand, studies with a series of knockout mice clearly demonstrated that neither µH chain nor surrogate L chain was a prerequisite for L chain gene rearrangement 13212627. Thus, the role of the pre-BCR in a L chain gene rearrangement remains an open question. /Igβ heterodimer was detected in association with calnexin on the surface of µH chain– pro-B cells, albeit at low levels, and was able to transduce signals across the cell membrane when cross-linked 2930. In vivo treatment of recombination activating gene (RAG)-2–deficient mice with anti-Igβ mAb revealed that cross-linking Igβ on developmentally arrested pro-B cells induced early B cell differentiation from pro-B to small pre-B cells 29. Therefore, we concluded that the antibody-mediated cross-linking of Igβ on pro-B cells mimicked the signal that is normally transduced via the pre-BCR. As it is extremely difficult to analyze the differentiation signal through pre-BCR itself, our novel system should provide a powerful tool for analyzing how pre-BCR signaling regulates differentiation events such as Ig gene rearrangements. However, it is impossible to examine the effects of Igβ cross-linking on Ig gene rearrangements using RAG-2–deficient mice because the recombination machinery necessary for rearrangements does not work in these mice 31. Therefore, we used µm-deficient mice, in which B cell development was completely arrested at the pro-B cell stage, as in RAG-2–deficient mice, but the recombination machinery was kept intact 12. Our results indicate that the signaling through Igβ, a component of the pre-BCR, regulates locus accessibility for ordered Ig gene rearrangement.
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Mice.
µm-deficient mice 12 and RAG-2–deficient mice 31 were provided by Dr. K. Rajewsky (University of Cologne, Germany) and Dr. F.W. Alt (Howard Hughes Medical Institute, Boston, MA, The Children's Hospital), respectively. They were bred and maintained under specific pathogen-free conditions in our animal facility and used for analysis at 8–12 wk of age. All of the experiments in this study were performed according to the Guidelines for Animal Use and Experimentation as set out by our Institutions.
FITC-conjugated anti-CD45R/B220 (RA3-6B2), PE-conjugated anti-CD45R/B220 (RA3-6B2), and biotin-conjugated antibodies specific to CD25 (7D4), CD117 (3C1), BP-1 (6C3), CD2 (RM2-5), and L chain (R5-240) were purchased from PharMingen. The mAb against 5 (LM34 32) was purified and labeled with biotin by standard methods. PE-conjugated streptavidin was purchased from Southern Biotechnology Associates, and allophycocyanin (APC)-conjugated streptavidin was provided by PharMingen. The mAb against mouse Igβ (HM79) was described previously 30.
Bone marrow cells were isolated from femurs and tibias of mice and suspended in staining buffer (PBS containing 0.1% BSA and 0.1% NaN3). For the enrichment of B lineage cells, B220+ cells were purified from bone marrow by using anti-CD45R (B220)–conjugated microbeads according to the procedure of the manufacturer (Miltenyi Biotec). More than 90% of the cells in the enriched population were found to express B220 (data not shown). Staining of bone marrow cells was performed as described 10. Debris, erythrocytes, and dead cells were excluded from the analysis by forward and side scatter and propidium iodide gatings. For cytoplasmic staining, bone marrow cells were fixed and permeabilized with Cytofix/Cytoperm kit (PharMingen) according to the manufacturer's instructions. Stained cells were analyzed by FACSCaliburTM (Becton Dickinson). Cell sorting was performed with a FACS VantageTM (Becton Dickinson).
Genomic DNA was prepared from B220+ bone marrow cells and subjected to PCR to detect V-J joints of the L chain gene. PCR conditions and primers were described previously 33. The PCR products were electrophoresed in 2% agarose gel, blotted onto nylon membranes, and then hybridized with 32P-labeled oligonucleotide probe J2-P (5'-GTGCCTCCACCGAACGTCCA-3'). The radioactivity was quantified with a Bio-Image analyzer (model BAS 2500; Fuji Photo Film Co. Ltd.). For reverse transcription (RT)-PCR, total RNA was prepared from B220+ bone marrow cells using Isogen (Nippon gene) and treated with RNase-free DNase (GIBCO BRL) to remove contaminating genomic DNA. cDNA was prepared using Moloney murine leukemia virus (MMLV) Reverse transcriptase RNaseH– (ReverTra Ace; Toyobo Co., Ltd.) and oligo dT or VHJ558 antisense primer 34. RT was carried out at 50°C. For VHJ558 germline transcripts, samples were amplified as described previously 34. For other genes, PCR was carried out with 25 cycles of 20 s at 94°C, 15 s at 55°C, and 1 min at 72°C. Sequences of the primers used for µ0 germline transcripts, VHJ558 germline transcripts, L chain germline transcripts, and hypoxanthine phosphoribosyl transferase (HPRT) have been described previously 34353637. Each PCR amplification was carried out within the logarithmic phase (data not shown). The PCR products were electrophoresed in 3% agarose gel, blotted onto nylon membranes, and hybridized with the following 32P-labeled probes: CH-P, 5'-GACAGCAACTGCGAGGTGGCT-3'; VHJ558-P, 5'-AAGGCCACACTGACTGCA-3'; J1-P, 5'-GTGCCTCCACCGAACGTCCA-3'; and HPRT-P, 5'-GCTGGTGAAAAGGACCTCT-3'.
Ligation-mediated PCR (LMPCR) assays were carried out as described 3839 with minor modification. In brief, genomic DNA from B220+ bone marrow cells was subjected to linker ligation at 16°C overnight in 10 µl ligation mixture (50 mM Tris [pH 7.4], 10 mM MgCl2, 20 mM dithiothreitol, 1 mM ATP, 5 µg/ml BSA, 10 pmol BW linker, and 2U T4 DNA ligase [Takara Shuzo]) and then heated to 95°C for 10 min to inactivate T4 ligase. Samples were subjected to nested PCR as described 3839 after normalization for DNA content by PCR amplification of RAG-1 gene as described previously 35. The PCR products were electrophoresed in 3% agarose gel, blotted onto nylon membranes and hybridized with the following 32P-labeled oligonucleotide probes: 5'DFL16.1-P, 5'-GCCCTGGCCAGTATGGTCTCTGGT-3'; 5'J1-P, 5'-CAGTGAGGAGGGTTTTTGTACAGCCAGACAG-3'; or RAG-1–P, 5'-AGGTAGCTTAGCCAACATGGCACG-3'.
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
B Cell Differentiation Is Induced in µm-deficient Mice When Treated with Anti-Igβ mAb.
µm-deficient mice were treated by a single injection of 1 mg of anti-Igβ mAb HM79. Flow cytometric analysis of their bone marrow cells isolated on day 6 after injection revealed that the expression of CD25 (Tac), BP-1, and CD2 on CD45R (B220)+ B lineage cells was upregulated, whereas that of 5 and CD117 (c-kit) was downregulated in the treated mice compared with control mice (Fig. 1, not all data shown). The average size of the CD45R (B220)+ cells was smaller than that of corresponding cells in untreated mice (data not shown). These phenotypic changes were very similar to those observed at the pro-B to small pre-B transition in normal B cell development. Thus, B cell differentiation could be induced by the cross-linking of Igβ on pro-B cells in µm-deficient mice, as previously observed in RAG-2–deficient mice 29, as long as judged by the phenotypic changes.
|
L chain genes, CD45R (B220)+ bone marrow cells were isolated from µm-deficient mice 6 d after the treatment with anti-Igβ mAb or PBS, and subjected to PCR analysis with a pair of primers specific for V and J2. Though low levels of PCR products corresponding to V-J1 and V-J2 joints could be detected even in untreated or PBS-treated mice, as described previously 2126, their levels were found 20 and 40 times higher, respectively, in the anti-Igβ–treated mice (Fig. 2 A). This indicates that the cross-linking of Igβ on pro-B cells promotes the production of V-J joints. To confirm the effect of Igβ cross-linking on L chain gene rearrangement, the expression of L chain protein was analyzed by flow cytometry. In accord with the PCR analysis, L chain was detectable in the cytoplasm of 
4% of CD45R (B220)+ bone marrow cells 6 d after the anti-Igβ treatment while hardly seen in those from control mice treated with PBS (Fig. 2 B). Thus, the cross-linking of Igβ on pro-B cells appeared to promote L chain gene rearrangements.
|
-J joints and L chain proteins among the B lineage population in the treated mice might not be due to the activation of rearrangements. It could be the consequence of preferential expansion of a minor population of cells that had already completed L chain gene rearrangements before the treatment. Therefore, we used the LMPCR assay, which reflects more accurately the amount of active V(D)J recombination at a particular locus because it detects intermediates in the recombination reaction rather than its end-products 38. DNA was prepared from CD45R (B220)+ bone marrow cells 6 d after the treatment with anti-Igβ mAb or PBS, and subjected to ligation with double strand linkers followed by nested PCR using a linker-specific primer and a pair of primers specific for the broken-ended RSS upstream of J1 3839. As shown in Fig. 3 (top), the frequency of intermediates of V-J rearrangement carrying broken-ended RSS upstream of J1 greatly increased in the anti-Igβ–treated µm-deficient mice compared with the PBS-treated mice. This clearly indicated that the antibody-mediated cross-linking of Igβ on pro-B cells indeed activated the recombination at the L chain loci.
|
Igβ Cross-Linking on Pro-B Cells Induces the Alteration of Accessibility at the H and L Chain Loci before the Induction of Surface Phenotypic Changes.
It has been shown that small pre-B cells in bone marrow of normal mice have a high activity of recombination at the L chain locus, but no activity at the H chain locus 39. Therefore, the alteration of recombination activity at the H and L chain loci observed in the CD45R (B220)+ bone marrow cells from µm-deficient mice might not be a primary effect of the Igβ cross-linking. It could be simply the consequence of the differentiation from pro-B cells to small pre-B cells induced by the anti-Igβ treatment. To address this issue, we analyzed the kinetics of the surface phenotypic changes of CD45R (B220)+ bone marrow cells after the treatment with anti-Igβ mAb, compared with the kinetics of the germline transcription at the H and L chain loci, which has been demonstrated to correlate strongly with rearrangement at those loci 4041.
As shown in Fig. 4 A, no apparent change was detected on day 1.5 after injection in the expression of CD25 and BP-1 on CD45R (B220)+ bone marrow cells, whereas their expression was upregulated on days 3 and 6. The kinetics of the proportion of CD25+ or BP-1+ cells among CD45R (B220)+ B lineage cells is summarized in Fig. 4 B. In parallel with the analysis of these surface markers, total RNA was prepared from CD45R (B220)+ bone marrow cells on days 0, 1.5, 3, and 6 after injection. Semiquantitative RT-PCR with specific primers revealed that the cross-linking of Igβ on pro-B cells induced a drastic reduction of VHJ558 germline transcripts derived from unrearranged VH segments, although µ0 germline transcripts stayed at almost the same levels (Fig. 5 A). On day 6, the amount of VHJ558 germline transcripts was diminished to approximately one fifth of that on day 0. Notably, threefold reduction of VHJ558 germline transcripts was detected as early as on day 1.5 after injection, even though no apparent change in the surface phenotype of pro-B cells was observed at that time (compare Fig. 4 B with Fig. 5 A). In contrast, the level of L chain germline transcripts derived from an unrearranged L chain gene was greatly upregulated as much as ninefold by day 6 after injection (Fig. 5 B). An approximately twofold increase of L chain germline transcripts was detected as early as day 1.5 after injection. To clarify the significance of this increase in the L chain germline transcripts before the induction of cellular differentiation, the level of L chain germline transcripts was further examined in BP-1– versus BP-1+ fraction sorted from CD45R (B220)+ bone marrow cells of µm-deficient mice 3 d after the treatment with anti-Igβ mAb or PBS (Fig. 6). As expected, BP-1+ differentiated cells from the anti-Igβ–treated mice expressed 5.9 times higher levels of L chain germline transcripts compared with BP-1– cells from the PBS-treated control mice (F2 versus F0 in Fig. 6 B). Intriguingly, a 3.6-fold increase of L chain germline transcripts was detected even in BP-1– undifferentiated cells from the anti-Igβ–treated mice compared with the corresponding cells from the control mice (F1 versus F0 in Fig. 6 B). Therefore, the upregulation of L chain germline transcripts appeared to start before the differentiation from BP-1– cells to BP-1+ cells. These results indicate that upon the anti-Igβ treatment, the L chain locus in pro-B cells became open and more accessible for recombinases, whereas the H chain locus became less accessible, even before the sign of cellular differentiation became detectable on the cell surface.
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
L chain germline transcripts and the downregulation of VH germline transcripts was detectable even before the cellular differentiation indicated by the change of surface phenotype. Therefore, the alteration of locus accessibility induced by the Igβ signaling is not simply a consequence of the differentiation of pro-B cells to small pre-B cells, where decreased accessibility at the H chain locus and increased accessibility at the L chain locus have been reported 383942. Our results strongly suggest that the signaling through the Ig/Igβ heterodimer of the pre-BCR is involved in the regulation of ordered Ig gene rearrangement by altering the accessibility of the H and L chain loci.
Previous studies with a series of knockout mice demonstrated that neither µH chain nor surrogate L chain was required for L chain gene rearrangement 13212627. In accord with this, low levels of L chain germline transcripts and some L chain gene rearrangements could be detected in bone marrow pro-B cells from µm-deficient mice. However, interestingly we found that the Igβ cross-linking on pro-B cells drastically increased L chain germline transcripts as well as the occurrence of L chain gene rearrangements. The induction of such L chain germline transcription was also observed in pro-B cells of RAG-deficient mice when the µH chain transgene was expressed 4344. Therefore, pre-BCR signaling via Igβ appears to facilitate opening the L chain loci for efficient access of recombinase even though it is not necessarily a prerequisite for the induction of L chain gene rearrangements.
The importance of Igβ in the allelic exclusion was previously demonstrated by creating mice carrying the transgene encoding the chimeric molecule between the µH chain and the Igβ cytoplasmic tail 45. Consistent with this, in our system used in this study, the in vivo cross-linking of Igβ on pro-B cells resulted in the suppression of rearrangements at the H chain locus as detected by LMPCR. We further demonstrated that VHJ588 germline transcripts in pro-B cells were downregulated to one third as early as day 1.5 after the anti-Igβ treatment, namely before cellular differentiation. This prompt closing of the H chain locus would be a mechanism of allelic exclusion at the H chain locus observed in normal B cell development, in that as soon as µH chain is produced through a functional VHDHJH rearrangement in one allele of the H chain gene, the rearrangement at the other allele is supposed to be prevented. Thus, the signaling through Igβ appears to be involved in allelic exclusion through altering the accessibility at the H chain locus. Since VH but not µ0 germline transcription was suppressed by Igβ cross-linking, the inaccessibility appears to be restricted to VH segments at the H chain locus. This is consistent with previous observations in µH chain transgenic mice 3842.
Another level of regulation in allelic exclusion has been proposed. It has been shown that RAG-2 proteins are quickly degraded during the S, G2, and M phases of the cell cycle 4647. Since the pre-BCR signal drives the cell cycle for several rounds of division 10, RAG-2 proteins produced during the pro-B cell stage for H gene rearrangement would be degraded rapidly in pre-BCR–expressing large pre-B cells. It seems reasonable that the pre-BCR signal leads to closing of the H chain locus and opening of the L chain locus while it downregulates the RAG activity. When the expression of surrogate L chain is shut off, most likely by pre-BCR signaling itself, and the RAG activity increases again 35, V(D)J recombinase targets the L chain locus but no longer the H chain locus. Thus, the pre-BCR appears to guarantee the allelic exclusion doubly by regulating both the recombinase and its target loci.
There has been much debate about what triggers pre-BCR signaling in normal B cell development, whether binding of a putative ligand or self-aggregation of the pre-BCR 17. Whether the surface expression of the pre-BCR is essential for its function is another important question 4849, since the expression level of the pre-BCR on the surface of pre-B cells is extremely low compared with that of the BCR, and the vast majority of the pre-BCR was detected intracellularly 1028. This study did not address those issues. Nevertheless, it clearly demonstrated that the Igβ complex on pro-B cells is fully competent to transduce signals across the cell membrane for cell differentiation and Ig gene rearrangements, though its expression level on the cell surface is extremely low and almost undetectable even by flow cytometry, as in the case of the pre-BCR 29. This favors the idea that the pre-BCR exerts its function on the cell surface in spite of its paucity.
The system described in this study is unique in that the ordered program of Ig gene rearrangements can be triggered in vivo by one shot of the antibody injection. Abelson murine leukemia virus (A-MuLV)–transformed pro-B and pre-B cell lines as well as Ig transgenic mice have been widely used to study the mechanism of Ig gene rearrangements 4181920363842434445. Our system has an advantage over those studies in that the antibody-mediated elicitation of transient and synchronous responses of pro-B cells allows us to examine the kinetics of each process in the rearrangement program, such as the alteration of chromatin structure and transcription in a particular locus. This approach should facilitate the elucidation of the mechanism by which the ordered Ig gene rearrangement is regulated during B cell development.
|
Acknowledgments |
|---|
This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture (Japan).
Submitted: 23 August 1999
Revised: 10 February 2000
Accepted: 16 February 2000
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Tonegawa S.. Somatic generation of antibody diversity, Nature., 302, 1983, 575–581.[Medline]
Alt F.W., Blackwell T.K. & Yancopoulos G.D.. Development of the primary antibody repertoire, Science., 238, 1987, 1079–1087.
Schatz D.G., Oettinger M.A. & Schlissel M.S.. V(D)J recombinationmolecular biology and regulation, Annu. Rev. Immunol., 10, 1992, 359–383.[Medline]
Alt F., Rosenberg N., Lewis S., Thomas E. & Baltimore D.. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cellsrearrangement of heavy but not light chain genes, Cell., 27, 1981, 381–390.[Medline]
Reth M.G., Ammirati P., Jackson S. & Alt F.W.. Regulated progression of a cultured pre-B-cell line to the B-cell stage, Nature., 317, 1985, 353–355.[Medline]
Rolink A. & Melchers F.. Molecular and cellular origins of B lymphocyte diversity, Cell., 66, 1991, 1081–1094.[Medline]
Rajewsky K.. Clonal selection and learning in the antibody system, Nature., 381, 1996, 751–758.[Medline]
Karasuyama H., Kudo A. & Melchers F.. The proteins encoded by the VpreB and 5 pre-B cell–specific genes can associate with each other and with µ heavy chain, J. Exp. Med., 172, 1990, 969–972.
Tsubata T. & Reth M.. The products of pre-B cell–specific genes (5 and VpreB) and the immunoglobulin µ chain form a complex that is transported onto the cell surface, J. Exp. Med., 172, 1990, 973–976.
Karasuyama H., Rolink A., Shinkai Y., Young F., Alt F.W. & Melchers F.. The expression of Vpre-B/5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice, Cell., 77, 1994, 133–143.[Medline]
Lassoued K., Nunez C.A., Billips L., Kubagawa H., Monteiro R.C., LeBlen T.W. & Cooper M.D.. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation, Cell., 73, 1993, 73–86.[Medline]
Kitamura D., Roes J., Kuhn R. & Rajewsky K.. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ chain gene, Nature., 350, 1991, 423–426.[Medline]
Kitamura D., Kudo A., Schaal S., Muller W., Melchers F. & Rajewsky K.. A critical role of 5 protein in B cell development, Cell., 69, 1992, 823–831.[Medline]
Yel L., Minegishi Y., Coustan-Smith E., Buckley R.H., Trubel H., Pachman L.M., Kitchingman G.R., Campana D., Rohrer J. & Conley M.E.. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia, N. Engl. J. Med., 335, 1996, 1486–1493.
Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D. & Conley M.E.. Mutations in the human 5/14.1 gene result in B cell deficiency and agammaglobulinemia, J. Exp. Med., 187, 1998, 71–77.
Melchers F., Karasuyama H., Haasner D., Bauer S., Kudo A., Sakaguchi N., Jameson B. & Rolink A.. The surrogate light chain in B-cell development, Immunol. Today., 14, 1993, 60–68.[Medline]
Karasuyama H., Rolink A. & Melchers F.. Surrogate light chain in B cell development, Adv. Immunol., 63, 1996, 1–41.[Medline]
Weaver D., Costantini F., Imanishi-Kari T. & Baltimore D.. A transgenic immunoglobulin mu gene prevents rearrangement of endogenous genes, Cell., 42, 1985, 117–127.[Medline]
Nussenzweig M.C., Shaw A.C., Sinn E., Danner D.B., Holmes K.L., Morse H.C. III & Leder P.. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin µ, Science., 236, 1987, 816–819.
Manz J., Denis K., Witte O., Brinster R. & Storb U.. Feedback inhibition of immunoglobulin gene rearrangement by membrane µ, but not by secreted µ heavy chains, J. Exp. Med., 168, 1988, 1363–1381.
Kitamura D. & Rajewsky K.. Targeted disruption of µ chain membrane exon causes loss of heavy-chain allelic exclusion, Nature., 356, 1992, 154–156.[Medline]
Loffert D., Ehlich A., Muller W. & Rajewsky K.. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development, Immunity., 4, 1996, 133–144.[Medline]
Reth M., Petrac E., Wiese P., Lobel L. & Alt F.W.. Activation of V gene rearrangement in pre-B cells follows the expression of membrane-bound immunoglobulin heavy chains, EMBO (Eur. Mol. Biol. Organ.) J., 6, 1987, 3299–3305.[Medline]
Iglesias A., Kopf M., Williams G.S., Buhler B. & Kohler G.. Molecular requirements for the µ-induced light chain gene rearrangement in pre-B cells, EMBO (Eur. Mol. Biol. Organ.) J., 10, 1991, 2147–2155.[Medline]
Tsubata T., Tsubata R. & Reth M.. Crosslinking of the cell surface immunoglobulin (µ-surrogate light chain complex) on pre-B cells induces activation of V gene rearrangements at the immunoglobulin locus, Int. Immunol., 4, 1992, 637–641.
Ehlich A., Schaal S., Gu H., Kitamura D., Muller W. & Rajewsky K.. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development, Cell., 72, 1993, 695–704.[Medline]
Chen J., Trounstine M., Alt F.W., Young F., Kurahara C., Loring J.F. & Huszar D.. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus, Int. Immunol., 5, 1993, 647–656.
Winkler T.H., Rolink A., Melchers F. & Karasuyama H.. Precursor B cells of mouse bone marrow express two different complexes with the surrogate light chain on the surface, Eur. J. Immunol., 25, 1995, 446–450.[Medline]
Nagata K., Nakamura T., Kitamura F., Kuramochi S., Taki S., Campbell K.S. & Karasuyama H.. The Ig/Igβ heterodimer on µ-negative proB cells is competent for transducing signals to induce early B cell differentiation, Immunity., 7, 1997, 559–570.[Medline]
Koyama M., Ishihara K., Karasuyama H., Cordell J.L., Iwamoto A. & Nakamura T.. CD79/CD79β heterodimers are expressed on pro-B cell surfaces without associated µ heavy chain, Int. Immunol., 9, 1997, 1767–1772.
Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M. & Alt F.W.. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement, Cell., 68, 1992, 855–867.[Medline]
Karasuyama H., Rolink A. & Melchers F.. A complex of glycoproteins is associated with VpreB/5 surrogate light chain on the surface of µ heavy chain–negative early precursor B cell lines, J. Exp. Med., 178, 1993, 469–478.
Caldwell R.G., Wilson J.B., Anderson S.J. & Longnecker R.. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals, Immunity., 9, 1998, 405–411.[Medline]
Corcoran A.E., Riddell A., Krooshoop D. & Venkitaraman A.R.. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor, Nature., 391, 1998, 904–907.[Medline]
Grawunder U., Leu T.M., Schatz D.G., Werner A., Rolink A.G., Melchers F. & Winkler T.H.. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement, Immunity., 3, 1995, 601–608.[Medline]
Schlissel M.S., Corcoran L.M. & Baltimore D.. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription, J. Exp. Med., 173, 1991, 711–720.
Maki K., Sunaga S. & Ikuta K.. The V-J recombination of T cell receptor-
genes is blocked in interleukin-7 receptor–deficient mice, J. Exp. Med., 184, 1996, 2423–2427.
Schlissel M., Constantinescu A., Morrow T., Baxter M. & Peng A.. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated, Genes Dev., 7, 1993, 2520–2532.
Constantinescu A. & Schlissel M.S.. Changes in locus-specific V(D)J recombinase activity induced by immunoglobulin gene products during B cell development, J. Exp. Med., 185, 1997, 609–620.
Yancopoulos G.D. & Alt F.W.. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments, Cell., 40, 1985, 271–281.[Medline]
Schlissel M.S. & Baltimore D.. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription, Cell., 58, 1989, 1001–1007.[Medline]
Stanhope-Baker P., Hudson K.M., Shaffer A.L., Constantinescu A. & Schlissel M.S.. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro, Cell., 85, 1996, 887–897.[Medline]
Spanopoulou E., Roman C.A., Corcoran L.M., Schlissel M.S., Silver D.P., Nemazee D., Nussenzweig M.C., Shinton S.A., Hardy R.R. & Baltimore D.. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice, Genes Dev., 8, 1994, 1030–1042.
Young F., Ardman B., Shinkai Y., Lansford R., Blackwell T.K., Mendelsohn M., Rolink A., Melchers F. & Alt F.W.. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation, Genes Dev., 8, 1994, 1043–1057.
Papavasiliou F., Misulovin Z., Suh H. & Nussenzweig M.C.. The role of Igβ in precursor B cell transition and allelic exclusion, Science., 268, 1995, 408–411.
Lin W.C. & Desiderio S.. Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation, Science., 260, 1993, 953–959.
Lin W.C. & Desiderio S.. Cell cycle regulation of V(D)J recombination-activating protein RAG-2, Proc. Natl. Acad. Sci. USA., 91, 1994, 2733–2937.
Aoki Y., Isselbacher K.J., Cherayil B.J. & Pillai S.. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells, Proc. Natl. Acad. Sci. USA., 91, 1994, 4204–4208.
Aoki Y., Isselbacher K.J. & Pillai S.. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells, Proc. Natl. Acad. Sci. USA., 91, 1994, 10606–10609.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
